HIV+/HCV+ | HIV−/HCV− | p-value | |
---|---|---|---|
Days of hospitalization | |||
°Mean ± SD | 9.6 ± 4.45 | 10.81 ± 3.71 | 0.6 |
Complications, n (%) | 2 (40) | 8 (72.72) | 0.299 |
Clavien-Dindo score, mean ± SD | 1 ± 1.41 | 1.36 ± 1.2 | 0.594 |
°< 2 | 4 (80) | 10 (90.91) | 0.99 |
°> 2 | 1 (20) | 1 (9.09) | |
Comprehensive complication index | |||
°Mean ± SD (min; max) | 12.8 ± 17.6 (0; 34) | 12.7 ± 11.2 (0; 34) | 0.815 |
°Median (25; 75° percentile) | 0 (0; 30) | 9 (4.5; 21.5) | |
Postoperative ascites, n (%) | 0 | 2 (18.18) | 0.99 |
Overall survival (months) | |||
°Mean ± SE | 36 ± 2.59 | 29.9 ± 3.49 | 0.443 |
°Death, n (%) | 1 (20) | 4 (36.36) | 0.99 |
°OS at 1 year | 100% | 90% | |
°OS at 3 years | 75% | 53.3% | |
Recurrence-free survival (months) | |||
°Mean ± SE | 27 ± 5.69 | 26.78 ± 4.41 | 0.873 |
°Relapse, n (%) | 2 (40) | 4 (36.36) | 1 |
°RFS at 1 year | 80% | 80.8% | |
°RFS at 3 years | 53.3% | 58.9% | |
Type of relapse, n (%) | |||
°Extrahepatic, n (%) | 0 | 0 | |
°Intrahepatic, n (%) | 2 | 4 | |
°Local recurrence, n (%) | 0 | 2 (50) | 0.467 |
°Distant intrahepatic, n (%) | 2 (100) | 2 (50) | |
Treatment of relapse, n (%) | |||
°Liver resection | 0 | 0 | |
°Termoablation | 0 | 1 (25) | |
°Liver transplant | 1 (50) | 0 | |
°TACE | 0 | 0 | 0.20 |
°Medical treatment | 0 | 3 (75) | |
°Palliative treatment | 1 (50) | 0 | |
°Other | 0 | 0 |